FDA, CBP, DJT: What’s News?

Episode Summary: In this tactical episode, FDA regulatory attorney Benjamin L. England explains the critical differences between FDA import refusals and Customs and Border Protection (CBP) seizures, and what businesses can do when their products are detained, refused, or seized. From legal definitions to strategic responses and mistakes to avoid, Ben outlines how to protect your goods, your company, and your import privileges. Whether you're facing a Notice of FDA Action or a CBP Seizure Notice, this episode provides a step-by-step breakdown of how to respond, and when to escalate. Timestamps: 00:00 – Introduction to Benjamin England and the topic 01:00 – Difference between an FDA refusal and a CBP seizure 02:30 – What triggers each enforcement action 04:00 – Deadlines and warning signs in detention notices 05:30 – First steps to take after receiving a notice 06:30 – Destruction vs. export procedures (including FDA supervision) 07:30 – Legal remedies: rescission, petition, or forfeiture 09:00 – Criteria for reversing FDA refusals 10:30 – When litigation is appropriate (or not) 12:30 – Why CBP is more litigation-friendly than FDA 13:30 – Most common mistakes importers make 15:00 – How CBP redelivery demands work after refusal 16:00 – When to hire an attorney for seizures or rescissions 17:00 – Compliance systems to avoid enforcement actions About the Show: FDA Imports: Cross-Border Compliance with Benjamin L. England is your go-to source for practical legal guidance on FDA, CBP, and global trade compliance. Hosted by attorney and regulatory strategist Benjamin L. England, each episode offers actionable insight for importers, manufacturers, and international companies facing regulatory enforcement.